Insider Selling: Milestone Scientific Inc. (NYSE:MLSS) Major Shareholder Sells 30,558 Shares of Stock

Milestone Scientific Inc. (NYSE:MLSS - Get Free Report) major shareholder S.R.L. Bp4 sold 30,558 shares of the company's stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $0.68, for a total transaction of $20,779.44. Following the completion of the sale, the insider owned 9,320,288 shares in the company, valued at approximately $6,337,795.84. This trade represents a 0.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Large shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.

S.R.L. Bp4 also recently made the following trade(s):

• On Tuesday, July 8th, S.R.L. Bp4 sold 11,489 shares of Milestone Scientific stock. The stock was sold at an average price of $0.69, for a total value of $7,927.41.
• On Thursday, July 3rd, S.R.L. Bp4 sold 50,853 shares of Milestone Scientific stock. The shares were sold at an average price of $0.67, for a total transaction of $34,071.51.
• On Monday, June 30th, S.R.L. Bp4 sold 649 shares of Milestone Scientific stock. The shares were sold at an average price of $0.65, for a total transaction of $421.85.
• On Friday, June 27th, S.R.L. Bp4 sold 10,000 shares of Milestone Scientific stock. The shares were sold at an average price of $0.73, for a total transaction of $7,300.00.
• On Wednesday, June 25th, S.R.L. Bp4 sold 1,300 shares of Milestone Scientific stock. The shares were sold at an average price of $0.77, for a total value of $1,001.00.
• On Tuesday, June 24th, S.R.L. Bp4 sold 10,000 shares of Milestone Scientific stock. The stock was sold at an average price of $0.81, for a total transaction of $8,100.00.
• On Monday, June 23rd, S.R.L. Bp4 sold 5,933 shares of Milestone Scientific stock. The stock was sold at an average price of $0.86, for a total value of $5,102.38.
• On Wednesday, June 18th, S.R.L. Bp4 sold 1,693 shares of Milestone Scientific stock. The stock was sold at an average price of $0.88, for a total value of $1,489.84.
• On Monday, June 16th, S.R.L. Bp4 sold 10,056 shares of Milestone Scientific stock. The stock was sold at an average price of $0.90, for a total transaction of $9,050.40.
• On Wednesday, June 11th, S.R.L. Bp4 sold 23,797 shares of Milestone Scientific stock. The shares were sold at an average price of $0.90, for a total transaction of $21,417.30.

Milestone Scientific Stock Down 0.6%

Shares of NYSE MLSS traded down $0.00 during mid-day trading on Friday, reaching $0.67. 30,710 shares of the company were exchanged, compared to its average volume of 120,147. The firm has a 50-day moving average of $0.86 and a 200 day moving average of $0.98. Milestone Scientific Inc. has a 1 year low of $0.57 and a 1 year high of $1.39. The stock has a market cap of $52.30 million, a price-to-earnings ratio of -9.52 and a beta of 0.80.

Analysts Set New Price Targets

Separately, Wall Street Zen initiated coverage on shares of Milestone Scientific in a report on Sunday, May 18th. They issued a "hold" rating for the company.

Institutional Trading of Milestone Scientific

Large investors have recently bought and sold shares of the stock. XTX Topco Ltd raised its stake in Milestone Scientific by 99.2% in the 1st quarter. XTX Topco Ltd now owns 34,135 shares of the company's stock worth $32,000 after acquiring an additional 17,002 shares during the last quarter. Brookwood Investment Group LLC purchased a new stake in shares of Milestone Scientific during the 1st quarter worth about $46,000. Finally, Renaissance Technologies LLC grew its holdings in Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock valued at $121,000 after purchasing an additional 53,198 shares during the period. Hedge funds and other institutional investors own 5.79% of the company's stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.